Search
Assembly Biosciences Inc
ASMBAdd to Watchlist
25.110USD
-0.950-3.65%
Close 07-31 16:00（ET）Quotes delayed by 15 min
497.60MMarket Cap
274.55P/E TTM
More Details of Assembly Biosciences Inc Company
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Its pipeline includes multiple clinical-stage investigational therapies, including two helicase-primase inhibitors (HPI) targeting recurrent genital herpes; an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, and a potent next-generation capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. Its pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses, which is undergoing studies to enable a regulatory filing, and it also has additional research programs against multiple antiviral targets. It is advancing two investigational long-acting HPI candidates, ABI-5366 (5366) and (2) ABI-1179 (1179).
Assembly Biosciences Inc Info
Ticker SymbolASMB
Company nameAssembly Biosciences Inc
IPO dateDec 17, 2010
CEO- -
Number of employees73
Security typeOrdinary Share
Fiscal year-endDec 17
AddressTwo Tower Place
CitySOUTH SAN FRANCISCO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94080
Phone18334094583
Websitehttps://www.assemblybio.com/
Ticker SymbolASMB
IPO dateDec 17, 2010
CEO- -
Company Executives of Assembly Biosciences Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Nicole S. White, Ph.D.
Dr. Nicole S. White, Ph.D.
Chief Manufacturing Officer
Chief Manufacturing Officer
47.63K
+83.58%
Dr. John G. McHutchison, M.D.
Dr. John G. McHutchison, M.D.
Director
Director
18.35K
+9.51%
Mr. Jason A. Okazaki
Mr. Jason A. Okazaki
President, Principal Executive Officer, Director
President, Principal Executive Officer, Director
17.67K
-513.33%
Sir Michael Houghton, Esq.
Sir Michael Houghton, Esq.
Independent Director
Independent Director
3.20K
--
Dr. Anuj Gaggar, M.D., Ph.D.
Dr. Anuj Gaggar, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
2.00K
-1900.00%
Mr. Anthony E. (Tony) Altig
Mr. Anthony E. (Tony) Altig
Independent Director
Independent Director
666.00
--
Mr. William R. Ringo ,
Mr. William R. Ringo ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Susan M. (Sue) Mahony, Ph.D.
Dr. Susan M. (Sue) Mahony, Ph.D.
Independent Director
Independent Director
--
--
Dr. William E. Delaney, IV, Ph.D.
Dr. William E. Delaney, IV, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Ms. Gina Consylman, CPA
Ms. Gina Consylman, CPA
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Nicole S. White, Ph.D.
Dr. Nicole S. White, Ph.D.
Chief Manufacturing Officer
Chief Manufacturing Officer
47.63K
+83.58%
Dr. John G. McHutchison, M.D.
Dr. John G. McHutchison, M.D.
Director
Director
18.35K
+9.51%
Mr. Jason A. Okazaki
Mr. Jason A. Okazaki
President, Principal Executive Officer, Director
President, Principal Executive Officer, Director
17.67K
-513.33%
Sir Michael Houghton, Esq.
Sir Michael Houghton, Esq.
Independent Director
Independent Director
3.20K
--
Dr. Anuj Gaggar, M.D., Ph.D.
Dr. Anuj Gaggar, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
2.00K
-1900.00%
Mr. Anthony E. (Tony) Altig
Mr. Anthony E. (Tony) Altig
Independent Director
Independent Director
666.00
--
FAQs
Who are the top five shareholders of Assembly Biosciences Inc?
The top five shareholders of Assembly Biosciences Inc are: Dr. Nicole S. White, Ph.D.
How many institutions hold shares of Assembly Biosciences Inc (ASMB)?
As of 2026Q1, 125 institutions hold shares of Assembly Biosciences Inc, with a combined market value of approximately 9.26M, accounting for 58.24% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 433311.00.